← Back to Search
Behavioural Intervention
Refer2Quit for Smoking Cessation
Philadelphia, PA
N/A
Recruiting
Led By Brian P Jenssen, MD, MSHP
Research Sponsored by Children's Hospital of Philadelphia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adult Intervention Subject: Males or females ages ≥18 years in age, self-identify as a current combustible tobacco user, have a valid cell phone number
Be older than 18 years old
Must not have
Adult Intervention Subject: <18 years in age, indicates no combustible tobacco smoking
Adult Control Subject: <18 years in age, indicates no combustible tobacco smoking
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 and 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial aims to see if a program called Refer2Quit can help household members who smoke to quit tobacco better than the usual treatment. They also want to understand what factors influence how well Refer2Quit
See full description
Who is the study for?
This trial is for household members who smoke and are interested in quitting. It's designed to see if a new approach, Refer2Quit, helps more people stop smoking compared to usual treatments. Specific characteristics of the participants and their families will also be studied.Check my eligibility
What is being tested?
The study tests the Refer2Quit intervention against standard quit-smoking strategies. Participants will either receive this new method or continue with the typical support available, allowing researchers to compare success rates between the two groups.See study design
What are the potential side effects?
Since this trial focuses on comparing different smoking cessation methods rather than testing a drug, it may not have direct side effects like medications do. However, quitting smoking can lead to withdrawal symptoms such as irritability, cravings, or difficulty concentrating.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 18 or older, smoke tobacco, and have a cell phone.
show original
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am an adult and I do not smoke.
show original
Select...
I am under 18 and do not smoke.
show original
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 and 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 and 6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Combustible tobacco quit rate at 1 and 6 months
The proportion of adult participants who engage in any evidence-based tobacco use treatments
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention ArmExperimental Treatment1 Intervention
Adult intervention arm participants will receive motivational counseling provided by the study staff member enrolling them. The study team member will offer 4 evidence-based treatment options (varenicline, NRT, quitline, and/or smokefreeTXT), emphasizing that the combination is often more effective than one treatment alone, and that they could start treatment even if they are not ready to quit.
Group II: Control ArmActive Control1 Intervention
Adult control arm participants will receive a handout listing tobacco treatment options that they can connect to on their own
Find a Location
Closest Location:Children's Hospital of Philadelphia· Philadelphia, PA· 416 miles
Who is running the clinical trial?
National Institutes of Health (NIH)NIH
2,894 Previous Clinical Trials
8,049,606 Total Patients Enrolled
38 Trials studying Smoking
14,524 Patients Enrolled for Smoking
Children's Hospital of PhiladelphiaLead Sponsor
748 Previous Clinical Trials
11,401,441 Total Patients Enrolled
1 Trials studying Smoking
30 Patients Enrolled for Smoking
National Cancer Institute (NCI)NIH
14,073 Previous Clinical Trials
41,179,916 Total Patients Enrolled
68 Trials studying Smoking
56,399 Patients Enrolled for Smoking
Brian P Jenssen, MD, MSHPPrincipal InvestigatorChildren's Hospital of Philadelphia